Jibiki M, Taniguchi Y, Matsuo T, Ikari H, Ishibashi T, Sugamura Y, Kunizaki T, Hirao K
Dept. of Surgery, Sasebo Chuo Hospital.
Gan To Kagaku Ryoho. 1997 Nov;24(14):2151-3.
We reported a 71-year-old male patient with multiple liver recurrence of hepatocellular carcinoma, who responded to arterial infusion chemotherapy using CDDP and 5-FU. The patient was administered 10mg/body CDDP and 250 mg/body 5-FU on day 1-5./1 course. As a result, the tumor decreased and AFP was decreased to 50.8 ng/ml (from 93099 ng/ml). The patient is alive 13 months after the beginning of therapy in a condition of partial response (PR).
我们报告了一名71岁男性肝细胞癌多发肝转移患者,其对使用顺铂和5-氟尿嘧啶的动脉灌注化疗有反应。患者在第1 - 5天接受10mg/体顺铂和250mg/体5-氟尿嘧啶治疗,1个疗程。结果,肿瘤缩小,甲胎蛋白降至50.8 ng/ml(从93099 ng/ml)。治疗开始13个月后,患者仍存活,处于部分缓解(PR)状态。